The activation of TRPV2 by lysophosphatidylcholine (LPC) and lysophosphatidylinositol (LPI) has been shown to induce calcium influx and increase cell migration in the prostate cancer cell line PC3, indicating the potential pathological role of TRPV2 in prostate cancer [183]. The gene discussed is TRPV2; the disease is prostate carcinoma.